Meng Pan

1.3k total citations
53 papers, 1.0k citations indexed

About

Meng Pan is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Meng Pan has authored 53 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 19 papers in Immunology and 16 papers in Oncology. Recurrent topics in Meng Pan's work include Immunotherapy and Immune Responses (11 papers), MicroRNA in disease regulation (9 papers) and Cancer Cells and Metastasis (9 papers). Meng Pan is often cited by papers focused on Immunotherapy and Immune Responses (11 papers), MicroRNA in disease regulation (9 papers) and Cancer Cells and Metastasis (9 papers). Meng Pan collaborates with scholars based in China, Bangladesh and South Korea. Meng Pan's co-authors include Zhiyong Qian, Danrong Hu, Yan Yu, Jun Dou, Liping Yuan, Ying Hao, Kun Shi, Fengshu Zhao, Jinrong Peng and Zhiyong Qian and has published in prestigious journals such as SHILAP Revista de lepidopterología, Biomaterials and Advanced Functional Materials.

In The Last Decade

Meng Pan

51 papers receiving 993 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Meng Pan China 19 416 346 212 180 166 53 1.0k
Shuang Zhou China 18 377 0.9× 224 0.6× 139 0.7× 288 1.6× 230 1.4× 35 1.1k
Dong Cen China 14 524 1.3× 492 1.4× 310 1.5× 108 0.6× 134 0.8× 37 1.1k
Chong Ma China 20 466 1.1× 321 0.9× 235 1.1× 197 1.1× 135 0.8× 54 1.2k
Marina Pöttler Germany 13 361 0.9× 416 1.2× 162 0.8× 325 1.8× 102 0.6× 22 1.2k
Yangyang Du China 15 462 1.1× 437 1.3× 145 0.7× 137 0.8× 178 1.1× 24 920
Fangyuan Xie China 20 362 0.9× 231 0.7× 70 0.3× 165 0.9× 100 0.6× 36 935
Dayun Yang China 22 457 1.1× 620 1.8× 106 0.5× 151 0.8× 101 0.6× 33 1.3k
Ming Cao China 19 739 1.8× 291 0.8× 464 2.2× 136 0.8× 125 0.8× 57 1.3k

Countries citing papers authored by Meng Pan

Since Specialization
Citations

This map shows the geographic impact of Meng Pan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meng Pan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meng Pan more than expected).

Fields of papers citing papers by Meng Pan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meng Pan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meng Pan. The network helps show where Meng Pan may publish in the future.

Co-authorship network of co-authors of Meng Pan

This figure shows the co-authorship network connecting the top 25 collaborators of Meng Pan. A scholar is included among the top collaborators of Meng Pan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meng Pan. Meng Pan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wan, Yongjie, et al.. (2025). Biomaterial-based drug delivery systems for the therapy of malignant pleural effusion. Chinese Chemical Letters. 37(1). 111513–111513.
2.
3.
4.
Chen, Yu, et al.. (2024). Cabazitaxel‐Loaded Thermosensitive Hydrogel System for Suppressed Orthotopic Colorectal Cancer and Liver Metastasis. Advanced Science. 11(33). e2404800–e2404800. 7 indexed citations
5.
Yang, Yun, Qingya Liu, Meng Wang, et al.. (2024). Genetically programmable cell membrane-camouflaged nanoparticles for targeted combination therapy of colorectal cancer. Signal Transduction and Targeted Therapy. 9(1). 158–158. 39 indexed citations
6.
Pan, Meng, Peng Chen, Qi Zhang, et al.. (2024). Comprehensive profiling of cell subsets of gastric cancer and liver metastasis based on single cell RNA-sequencing analysis. Translational Cancer Research. 13(1). 330–347. 2 indexed citations
7.
Pan, Meng, et al.. (2023). UTP18-mediated p21 mRNA instability drives adenoma-carcinoma progression in colorectal cancer. Cell Reports. 42(5). 112423–112423. 6 indexed citations
8.
9.
Pan, Meng, Danrong Hu, Liping Yuan, et al.. (2022). Newly developed gas-assisted sonodynamic therapy in cancer treatment. Acta Pharmaceutica Sinica B. 13(7). 2926–2954. 37 indexed citations
10.
Zhang, Yin, Chunyuan Li, Meng Pan, et al.. (2021). Exploration of the Key Proteins of High-Grade Intraepithelial Neoplasia to Adenocarcinoma Sequence Using In-Depth Quantitative Proteomics Analysis. Journal of Oncology. 2021. 1–13. 10 indexed citations
11.
Yang, Fan, Kun Shi, Ying Hao, et al.. (2021). Cyclophosphamide loaded thermo-responsive hydrogel system synergize with a hydrogel cancer vaccine to amplify cancer immunotherapy in a prime-boost manner. Bioactive Materials. 6(10). 3036–3048. 54 indexed citations
12.
Wang, Xia, et al.. (2020). Comparison of proteome alterations during aging in the temporal lobe of humans and rhesus macaques. Experimental Brain Research. 238(9). 1963–1976. 2 indexed citations
13.
Li, Miao, Meng Pan, Jing Wang, et al.. (2020). miR-7 Reduces Breast Cancer Stem Cell Metastasis via Inhibiting RELA to Decrease ESAM Expression. Molecular Therapy — Oncolytics. 18. 70–82. 28 indexed citations
14.
Pan, Meng, et al.. (2020). Colorectal cancer stem cell vaccine with high expression of MUC1 serves as a novel prophylactic vaccine for colorectal cancer. International Immunopharmacology. 88. 106850–106850. 18 indexed citations
15.
Xu, Yanan, Xiaoyu Huang, Fengzhan Li, et al.. (2020). IL-21 enhances STAT3/Blimp-1 signaling pathway in B cells and contributes to plasma cell differentiation in newly diagnosed patients with myasthenia gravis. Immunologic Research. 69(1). 59–70. 11 indexed citations
16.
Yang, Fan, Kun Shi, Yanpeng Jia, et al.. (2020). A biodegradable thermosensitive hydrogel vaccine for cancer immunotherapy. Applied Materials Today. 19. 100608–100608. 47 indexed citations
17.
Wang, Xiaoying, Fengshu Zhao, Fangfang Shi, et al.. (2016). Reinforcing B16F10/GPI-IL-21 vaccine efficacy against melanoma by injecting mice with shZEB1 plasmid or miR200c agomir. Biomedicine & Pharmacotherapy. 80. 136–144. 11 indexed citations
18.
Li, Miao, Fei Xiong, Fangfang Shi, et al.. (2016). Homoharringtonine delivered by high proportion PEG of long- circulating liposomes inhibits RPMI8226 multiple myeloma cells in vitro and in vivo.. PubMed. 8(3). 1355–68. 7 indexed citations
19.
Chen, Wei‐xian, Shanliang Zhong, Minghua Ji, et al.. (2013). MicroRNAs delivered by extracellular vesicles: an emerging resistance mechanism for breast cancer. Tumor Biology. 35(4). 2883–2892. 51 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shuang Zhou Breakdown of academic impact, for papers by Dong Cen Breakdown of academic impact, for papers by Chong Ma Breakdown of academic impact, for papers by Marina Pöttler Breakdown of academic impact, for papers by Yangyang Du Breakdown of academic impact, for papers by Fangyuan Xie Breakdown of academic impact, for papers by Dayun Yang Breakdown of academic impact, for papers by Ming Cao
Rankless by CCL
2026